Immunogenicity assay of the Leishmune(®) vaccine against canine visceral leishmaniasis in Brazil

Leishmune(®) is the industrialized version of the FML-saponin vaccine which has been shown to develop 92–95% protection in vaccinated dogs and 76–80% vaccine efficacy against field canine visceral leishmaniasis (CVL) in Brazil. Leishmune(®) has been proven to be safe and tolerable and a transmission...

Descripción completa

Detalles Bibliográficos
Autores principales: Borja-Cabrera, G.P., Santos, F.N., Bauer, F.S., Parra, L.E., Menz, I., Morgado, A.A., Soares, I.S., Batista, L.M.M., Palatnik-de-Sousa, C.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2008
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173152/
https://www.ncbi.nlm.nih.gov/pubmed/18675868
http://dx.doi.org/10.1016/j.vaccine.2008.07.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173152/
https://www.ncbi.nlm.nih.gov/pubmed/18675868
http://dx.doi.org/10.1016/j.vaccine.2008.07.029

Ejemplares similares